OA11281A - Alatrofloxacin parenteral compositions. - Google Patents

Alatrofloxacin parenteral compositions. Download PDF

Info

Publication number
OA11281A
OA11281A OA1200000019A OA1200000019A OA11281A OA 11281 A OA11281 A OA 11281A OA 1200000019 A OA1200000019 A OA 1200000019A OA 1200000019 A OA1200000019 A OA 1200000019A OA 11281 A OA11281 A OA 11281A
Authority
OA
OAPI
Prior art keywords
compound
formula
parentéral
resin
process according
Prior art date
Application number
OA1200000019A
Other languages
English (en)
Inventor
Subramanian Sam Guhan
Robert Mark Guinn
John Francis Lambert
Stanley Walter Walinsky
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA11281A publication Critical patent/OA11281A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
OA1200000019A 1997-08-01 2000-01-26 Alatrofloxacin parenteral compositions. OA11281A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
OA11281A true OA11281A (en) 2002-11-19

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200000019A OA11281A (en) 1997-08-01 2000-01-26 Alatrofloxacin parenteral compositions.

Country Status (40)

Country Link
US (1) US6194429B1 (is)
EP (1) EP1000086B1 (is)
JP (1) JP3463928B2 (is)
KR (1) KR20010022495A (is)
CN (1) CN1265671A (is)
AP (1) AP1031A (is)
AR (1) AR015417A1 (is)
AT (1) ATE259827T1 (is)
AU (1) AU734863B2 (is)
BG (1) BG104105A (is)
BR (1) BR9811580A (is)
CA (1) CA2296466C (is)
CO (1) CO4970688A1 (is)
DE (1) DE69821767T2 (is)
DK (1) DK1000086T3 (is)
DZ (1) DZ2576A1 (is)
EA (1) EA002120B1 (is)
ES (1) ES2214716T3 (is)
GT (1) GT199800112A (is)
HN (1) HN1998000106A (is)
HR (1) HRP980417B1 (is)
HU (1) HUP0004793A3 (is)
ID (1) ID24374A (is)
IL (1) IL134156A0 (is)
IS (1) IS5339A (is)
MA (1) MA24626A1 (is)
NO (1) NO20000485L (is)
NZ (1) NZ502249A (is)
OA (1) OA11281A (is)
PA (1) PA8456701A1 (is)
PE (1) PE103799A1 (is)
PL (1) PL338477A1 (is)
PT (1) PT1000086E (is)
SK (1) SK1012000A3 (is)
TN (1) TNSN98146A1 (is)
TW (1) TW538043B (is)
UY (1) UY25113A1 (is)
WO (1) WO1999006430A1 (is)
YU (1) YU2500A (is)
ZA (1) ZA986874B (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ECSP003699A (es) * 1999-10-08 2002-04-23 Smithkline Beecham Corp Inhibidores de fab i
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
DE60230934D1 (de) 2001-04-06 2009-03-05 Affinium Pharm Inc Fab-i-inhibitoren
EP1575951B1 (en) 2002-12-06 2014-06-25 Debiopharm International SA Heterocyclic compounds, methods of making them and their use in therapy
WO2004082586A2 (en) 2003-03-17 2004-09-30 Affinium Pharmaceuticals, Inc. Phamaceutical compositions comprising inhibitors of fab i and further antibiotics
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
US8450307B2 (en) 2004-06-04 2013-05-28 Affinium Pharmaceuticals, Inc. Therapeutic agents, and methods of making and using the same
CA2632476A1 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
EP2687533B1 (en) 2006-07-20 2017-07-19 Debiopharm International SA Acrylamide derivatives as FAB I inhibitors
WO2008098374A1 (en) * 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
KR101720885B1 (ko) 2012-06-19 2017-03-28 데비오팜 인터네셔날 에스 에이 (e)-n-메틸-n-((3-메틸벤조푸란-2-일)메틸)-3-(7-옥소-5,6,7,8-테트라히드로-1,8-나프티리딘-3-일)아크릴아미드의전구약물 유도체
RU2716164C2 (ru) * 2014-04-25 2020-03-06 Наурекс, Инк. Стабильные композиции нейроактивных пептидов
RS61312B1 (sr) 2016-02-26 2021-02-26 Debiopharm Int Sa Lek za lečenje infekcija dijabetskog stopala
CA3087898A1 (en) 2018-02-02 2019-08-08 Ripple Therapeutics Corporation Glass formulations comprising steroid dimers and uses thereof
WO2020154815A1 (en) 2019-02-01 2020-08-06 Ripple Therapeutics Corporation Crystalline forms of dexamethasone dimers and uses thereof
MY203711A (en) 2019-02-14 2024-07-15 Debiopharm Int Sa Afabicin formulation, method for making the same and uses thereof
JP7418475B2 (ja) 2019-06-14 2024-01-19 デバイオファーム インターナショナル エス．エー． バイオフィルムが関与する細菌感染症を治療するための医薬及びその使用
US12509469B2 (en) 2019-08-07 2025-12-30 Ripple Therapeutics Corporation Compositions and methods for the treatment of pain and dependence disorders
JP2023524494A (ja) 2020-05-01 2023-06-12 リップル セラピューティクス コーポレーション 眼障害を処置するためのヘテロ二量体組成物と方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
RU2147303C1 (ru) 1994-01-18 2000-04-10 Пфайзер Инк. Промежуточные продукты и способ получения солей нафтиридонкарбоновой кислоты
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
CA2223404C (en) 1995-06-06 2001-01-16 Thomas A. Morris Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt
US5939550A (en) * 1995-06-15 1999-08-17 Pfizer Inc. Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide
IL122652A (en) * 1995-08-29 2000-01-31 Pfizer Polymorphs of the pro drug 6-n-(l-ala-l-ala)- trovafloxacin their preparation and pharmaceutical compositions containing them
PL325170A1 (en) 1995-08-29 1998-07-06 Pfizer Bipolar forms of throwaflocacin
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
JP2001512133A (ja) 2001-08-21
PE103799A1 (es) 1999-10-25
HUP0004793A2 (hu) 2001-04-28
DE69821767T2 (de) 2005-01-13
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
KR20010022495A (ko) 2001-03-15
NO20000485L (no) 2000-03-27
TNSN98146A1 (fr) 2005-03-15
CA2296466A1 (en) 1999-02-11
PT1000086E (pt) 2004-05-31
AU8236898A (en) 1999-02-22
IL134156A0 (en) 2001-04-30
NZ502249A (en) 2001-11-30
EP1000086A1 (en) 2000-05-17
DE69821767D1 (de) 2004-03-25
BG104105A (bg) 2000-08-31
CA2296466C (en) 2003-04-15
SK1012000A3 (en) 2000-09-12
IS5339A (is) 2000-01-14
JP3463928B2 (ja) 2003-11-05
GT199800112A (es) 2000-01-15
DK1000086T3 (da) 2004-05-17
ID24374A (id) 2000-07-13
HN1998000106A (es) 1999-01-08
WO1999006430A1 (en) 1999-02-11
AU734863B2 (en) 2001-06-21
MA24626A1 (fr) 1999-04-01
CN1265671A (zh) 2000-09-06
YU2500A (sh) 2002-09-19
AP1031A (en) 2001-12-21
HRP980417A2 (en) 1999-08-31
EA002120B1 (ru) 2001-12-24
AR015417A1 (es) 2001-05-02
US6194429B1 (en) 2001-02-27
UY25113A1 (es) 2000-12-29
NO20000485D0 (no) 2000-01-31
CO4970688A1 (es) 2000-11-07
HRP980417B1 (en) 2002-10-31
ZA986874B (en) 2000-01-31
AP9801310A0 (en) 1998-09-30
HUP0004793A3 (en) 2001-10-29
ATE259827T1 (de) 2004-03-15
EP1000086B1 (en) 2004-02-18
ES2214716T3 (es) 2004-09-16
EA200000086A1 (ru) 2000-08-28
BR9811580A (pt) 2000-08-22
PA8456701A1 (es) 2000-05-24
DZ2576A1 (fr) 2003-02-22

Similar Documents

Publication Publication Date Title
AP1031A (en) Alatrofloxacin parental compositions.
IE882363L (en) Quinolone and naphthyridine antibacterial agents containing an alpha-amino acid in the side chain of the 7-substituent
US5763454A (en) Crystal form of anhydrous 7-( 1α,5α,6α!-6-amino-3-azabicyclo 3.1.0!hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8 naphthyridine-3-carboxylic acid, methanessulfonic acid salt
EP3784649B1 (en) Process for the synthesis of (s)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid
AU653024B2 (en) Substituted diaminophthalimides and analogues
US20260015340A1 (en) Compound including 2,4-diaminopyridine, preparation method therefor, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer
US10550125B2 (en) Prodrugs of imidazotriazine compounds as CK2 inhibitors
CA2229786C (en) Zwitterionic forms of trovafloxacin
EP0847400B1 (en) Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
MXPA00001142A (en) Alatrofloxacin parenteral compositions
JPH0848629A (ja) ピリドンカルボン酸誘導体およびそれを有効成分とする抗ピロリ菌剤
EP0930297B1 (en) A process for preparing naphthyridones and intermediates
JPS62267228A (ja) 抗菌剤
HK1027361A (en) Alatrofloxacin parenteral compositions
HK40048148A (en) Process for the synthesis of (s)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid
HK40048148B (en) Process for the synthesis of (s)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid
OA11152A (en) Process for preparing trovafloxacin acid salts
CZ2000224A3 (cs) Alatrofloxacinové paranterální kompozice